Study for people with Prostate Cancer

Recruiting Not a phased study

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Not a phased study
Sponsor Prostate Cancer Clinical Trials Consortium
Registry number NCT03151629
Started 21 July 2017 Today 16 October 2026 Estimated completion 1 January 2031

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Royal Brisbane & Women's Hospital Herston Australia Recruiting
St. Vincent's Hospital Sydney Darlinghurst NSW Recruiting
Macquarie University Sydney NSW Recruiting
Westmead Hospital Sydney NSW Recruiting
Redland Hospital Cleveland QLD Recruiting
Princess Alexandra Hospital Woolloongabba QLD Recruiting
Eastern Health (Box Hill Hospital) Box Hill VIC Recruiting
Peter MacCallum Cancer Centre Melbourne VIC Recruiting
Epworth Healthcare Mount Waverley VIC Recruiting
Australian Urology Associates Melbourne Australia Recruiting
Australian Prostate Centre Melbourne N. Australia Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 21 Years and over
Sex Male participants only
Healthy volunteers Not accepted
Enrolment target 5000

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

• Willing and able to provide written informed consent and privacy authorization for the release of personal health information.

NOTE: Privacy authorization may be either included in the informed consent or obtained separately.

* Males 21 years of age and above

* Histological or cytological confirmed prostate adenocarcinoma from TRUS biopsy, radical prostatectomy or TURP Or Documented histopathology or cytopathology of prostate adenocarcinoma from a biopsy of a metastatic site Or Metastatic disease typical of prostate cancer (i.e., involving bone or pelvic lymph nodes or para-aortic lymph nodes) AND a serum concentration of PSA \>20ng/mL at the time of initial prostate cancer diagnosis

* No previous diagnosis of a second, non-prostate malignancy that requires additional systemic therapy except cancer in situ of bladder and basal cell cancer of skin

Dates on the record

Started 21 July 2017
Estimated completion 1 January 2031
Registry last updated 22 May 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 22 May 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.